Polypeptide Laboratories Inc

Meet us at TIDES Europe 2026 3-5 November 2026, Amsterdam, Netherlands Learn more and schedule a meeting Half-year results 2026 We’re proud to share our results for the first half of 2026 Read more Press release Samsung Biologics announces tender offer to acquire PolyPeptide Group AG for CHF 44. Read more Creating the future in peptides We lead innovation in peptide API’s to the benefit of millions of patients Contact us Expert views See our latest scientific publications and presentations by our experts. Read more Market leader in peptide API manufacturing and services PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API).